Search Results

Venlafaxine Hydrochloride 500 mg  | ≥98%

LKT Laboratories, Inc.

SERT, NET, MAO inhibitor.

More Information Supplier Page

×

Venlafaxine Hydrochloride

S-(−)-Carbidopa Monohydrate 100 mg  | ≥98%

LKT Laboratories, Inc.

Hydrazine; L-amino acid decarboxylase inhibitor.

More Information Supplier Page

×

S-(−)-Carbidopa Monohydrate

S-(−)-Carbidopa Monohydrate 25 mg  | ≥98%

LKT Laboratories, Inc.

Hydrazine; L-amino acid decarboxylase inhibitor.

More Information Supplier Page

×

S-(−)-Carbidopa Monohydrate

Vidarabine 1 g  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; viral DNA polymerase and ribonucleotide reductase inhibitor.

More Information Supplier Page

×

Vidarabine

Vidarabine 500 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (adenosine) analog; viral DNA polymerase and ribonucleotide reductase inhibitor.

More Information Supplier Page

×

Vidarabine

Leptomycin B 5 µg  | ≥98%

LKT Laboratories, Inc.

Polyketide; CRM1 inhibitor.

More Information Supplier Page

×

Leptomycin B

Leptomycin B 1 µg  | ≥98%

LKT Laboratories, Inc.

Polyketide; CRM1 inhibitor.

More Information Supplier Page

×

Leptomycin B

Kendomycin 500 µg  | ≥98%

LKT Laboratories, Inc.

Macrolide; ET antagonist, proteasome inhibitor.

More Information Supplier Page

×

Kendomycin

Kendomycin 500 µg  | ≥98%

LKT Laboratories, Inc.

Macrolide; ET antagonist, proteasome inhibitor.

More Information Supplier Page

×

Kendomycin

Taxane Standard Mixture 500 µl  | ≥98%

LKT Laboratories, Inc.

Mixture of taxanes.

More Information Supplier Page

×

Taxane Standard Mixture